Tracking Cathie Wood: Three consecutive days of increasing positions in low-altitude economy stock JOBY, buying Robinhood on dips; continuing to sell streaming company ROKU

On Thursday Eastern Time, as the conflict surrounding Iran continued to escalate and spill over into regions beyond the Middle East, US stocks experienced significant turbulence, global market volatility increased, and oil prices surged to their highest levels since mid-2024.

The Dow Jones Industrial Average fell by more than 1,100 points intraday but recovered some losses in the afternoon. The other two major indices also rebounded from their intraday lows, ultimately closing slightly lower.

Overnight, ARK's trading demonstrated a strong 'venture capital mindset' and probabilistic approach, decisively abandoning outdated hardware tools and traditional traffic entry points while accelerating the deployment of highly explosive new positions on the dual frontiers of the physical and digital worlds.

Buying Focus: Continued increase in low-altitude economy, AI healthcare, and digital financial ecosystem.

Buying activities were sharp on the day, with funds highly concentrated on emerging sectors expected to experience non-linear growth, especially with resolute bets placed on the low-altitude economy and medical frontiers.

Cathie Wood significantly added to her position in the leading electric vertical takeoff and landing (eVTOL) company $Joby Aviation (JOBY.US)$ 94,000 shares. This move directly hits the core of current hardcore tech investment.In the evolution logic of the robotics and automation industry, when core components gradually mature, using the 'complete machine' as a physical carrier to achieve a commercial closed loop is key to building long-term barriers. eVTOL is essentially the strongest 'machine carrier' for embodied intelligence in three-dimensional low-altitude space. ARK’s continuous heavy bet on JOBY represents a high-probability wager on the commercialization of the next-generation 3D transportation network.

In addition,She aggressively purchased a blood safety technology company $Cerus (CERS.US)$ as much as 612,500 shares, ranking at the top of her buy list. At the same time, she increased holdings in a mental health biotech company. $COMPASS Pathways (CMPS.US)$ 100,300 shares, as well as targeted protein degradation therapy $Nurix Therapeutics (NRIX.US)$ 43,500 shares.

ARK's offensive in the healthcare sector is highly penetrating. The significant purchase of CMPS represents capital seeking breakthroughs beyond traditional targeted drugs by exploring cognitive science and novel psychiatric therapies; while increasing positions in CERS and NRIX demonstrates precise positioning in the underlying innovations of next-generation clinical treatment technologies, aiming to capture non-linear growth curves.

Additionally,Its substantial increase in holdings at the US retail investor hub $Robinhood (HOOD.US)$ 183,900 shares.With the cyclical resonance of the cryptocurrency market and the rise in investor trading activity, HOOD, which boasts a large young user base and excellent UI/UX experience, is becoming a highly elastic play to capture this wave of financial liquidity dividends.

Sell-side focus: Liquidating satellite communications, continuing to clear out software stocks

Cathie Wood aggressively dumped satellite communications company $Iridium Communications (IRDM.US)$ 131,400 shares, ranking at the top of the sell list.The evolution of the space economy is brutally competitive. Within the landscape of commercial aerospace, traditional satellite operators face severe disruptive pressures from new low-cost launch service providers and large-scale low-orbit satellite networks. Rapidly reducing exposure to these outdated space infrastructures is an inevitable move in response to fundamental industrial restructuring.

In addition, it has drastically cut its holdings in life science tools companies $Standard BioTools (LAB.US)$ by 129,800 shares, and reduced its stake in single-cell sequencing giant $10x Genomics (TXG.US)$ by 57,700 shares.While heavily investing in novel therapies on the buying side, ARK continues to divest its holdings in standalone medical testing hardware and traditional genomic tools. In the absence of a strong AI data ecosystem, the growth ceiling for pure medical hardware devices is being reassessed by the market.

Additionally,It continued to liquidate its stake in the community social platform $Nextdoor Holdings (NXDR.US)$ by 58,800 shares, as well as the streaming software $Roku Inc (ROKU.US)$ by 67,100 shares.In an era where AI recommendation algorithms and short videos dominate everything, the traffic红利 of graphic communities and traditional streaming media entrances has peaked. Removing these assets that lack hardcore AI catalysts from the core arsenal is key to improving capital efficiency.

Finally, Cathie Wood also slightly reduced her stake in automated testing equipment $Teradyne (TER.US)$ by 6,645 shares, as well as IT operations SaaS $PagerDuty (PD.US)$3,144 shares.The reduction in TER reflects a shift in the semiconductor capital expenditure cycle, where funds are rotating from the upstream supply chain segment of testing hardware to more explosive application layers; the reduction in PD once again confirms the market's continued pessimism towards the monetization capabilities of traditional enterprise software.

Futubull's [Opportunities Page] has launched a feature to track celebrity portfolio opportunities! Choose from multiple celebrity portfolios, one-click follow the moves of top investors, precisely lock in high-quality stocks, and invest with greater confidence!

245K Views